SENS
NASDAQ
$5.11
Senseonics Holdings Inc (SENS)
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.
Sector:
Healthcare
Industry:
Medical Devices
Hold
Target: $13.40 (+162.23%)
Market Cap
$215M
Revenue 5Y CAGR
+70.72%
Free Cash Flow Yield
-34.93%
Beta (5Y)
1.61
Price Chart
Valuation
Market Cap$215M
Forward P/E21.01
P/S6.45
P/B8.05
Profitability
Total Revenue (TTM)$26M
Gross Profit (TTM)$21M
EBITDA-$132M
Profit Margin-214.2%
Operating Margin-271.9%
EPS-$3.28
Financial Health
Debt-to-Equity104.6%
Free Cash Flow Yield-34.93%
Growth & Risk
EPS 5Y CAGR-31.58%
Revenue 5Y CAGR+70.72%
FCF 5Y CAGR+6.59%
Beta (5Y)1.61
Sharpe Ratio-0.74